First Horizon Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121K | Buy |
3,155
+2,134
| +209% | +$81.5K | ﹤0.01% | 662 |
|
|
2025
Q1 | $39.6K | Buy |
1,021
+444
| +77% | +$16.3K | ﹤0.01% | 1041 |
|
|
2024
Q4 | $19.5K | Sell |
577
-321
| -36% | -$11.6K | ﹤0.01% | 1340 |
|
|
2024
Q3 | $36.7K | Buy |
898
+443
| +97% | +$18.1K | ﹤0.01% | 1124 |
|
|
2024
Q2 | $17.5K | Sell |
455
-744
| -62% | -$31.3K | ﹤0.01% | 1333 |
|
|
2024
Q1 | $51.4K | Buy |
1,199
+35
| +3% | +$1.44K | ﹤0.01% | 928 |
|
|
2023
Q4 | $43.2K | Sell |
1,164
-113
| -9% | -$4.06K | ﹤0.01% | 1005 |
|
|
2023
Q3 | $46.3K | Buy |
1,277
+278
| +28% | +$9.87K | ﹤0.01% | 885 |
|
|
2023
Q2 | $35.6K | Buy |
999
+65
| +7% | +$2.33K | ﹤0.01% | 1034 |
|
|
2023
Q1 | $33.3K | Buy |
934
+249
| +36% | +$8.71K | ﹤0.01% | 1075 |
|
|
2022
Q4 | $24.1K | Sell |
685
-239
| -26% | -$7.96K | ﹤0.01% | 1194 |
|
|
2022
Q3 | $26K | Sell |
924
-182
| -16% | -$6.9K | ﹤0.01% | 1123 |
|
|
2022
Q2 | $59K | Buy |
1,106
+892
| +417% | +$49.2K | ﹤0.01% | 873 |
|
|
2022
Q1 | $12K | Buy |
214
+72
| +51% | +$3.91K | ﹤0.01% | 1046 |
|
|
2021
Q4 | $7K | Sell |
142
-284
| -67% | -$14.8K | ﹤0.01% | 1651 |
|
|
2021
Q3 | $20K | Sell |
426
-424
| -50% | -$21.3K | ﹤0.01% | 1280 |
|
|
2021
Q2 | $42K | Hold |
850
| – | – | ﹤0.01% | 847 |
|
|
2021
Q1 | $37K | Sell |
850
-250
| -23% | -$11.3K | ﹤0.01% | 850 |
|
|
2020
Q4 | $50K | Sell |
1,100
-2,555
| -70% | -$117K | ﹤0.01% | 600 |
|
|
2020
Q3 | $171K | Buy |
3,655
+23
| +0.6% | +$1.15K | 0.01% | 323 |
|
|
2020
Q2 | $184K | Sell |
3,632
-276
| -7% | -$14.2K | 0.01% | 314 |
|
|
2020
Q1 | $185K | Sell |
3,908
-87
| -2% | -$4.64K | 0.02% | 298 |
|
|
2019
Q4 | $234K | Buy |
3,995
+309
| +8% | +$17.2K | 0.02% | 317 |
|
|
2019
Q3 | $196K | Sell |
3,686
-8
| -0.2% | -$412 | 0.02% | 328 |
|
|
2019
Q2 | $184K | Buy |
3,694
+125
| +4% | +$6.27K | 0.01% | 353 |
|
|
2019
Q1 | $185K | Buy |
3,569
+895
| +33% | +$44.7K | 0.01% | 346 |
|
|
2018
Q4 | $127K | Sell |
2,674
-699
| -21% | -$34.4K | 0.01% | 388 |
|
|
2018
Q3 | $169K | Buy |
3,373
+351
| +12% | +$17.8K | 0.01% | 388 |
|
|
2018
Q2 | $151K | Sell |
3,022
-1,122
| -27% | -$56.5K | 0.01% | 393 |
|
|
2018
Q1 | $209K | Buy |
4,144
+1,154
| +39% | +$53.7K | 0.02% | 303 |
|
|
2017
Q4 | $135K | Buy |
2,990
+6
| +0.2% | +$277 | 0.01% | 361 |
|
|
2017
Q3 | $152K | Sell |
2,984
-4
| -0.1% | -$203 | 0.02% | 337 |
|
|
2017
Q2 | $146K | Buy |
2,988
+431
| +17% | +$23K | 0.02% | 336 |
|
|
2017
Q1 | $129K | Sell |
2,557
-1,488
| -37% | -$75.5K | 0.01% | 370 |
|
|
2016
Q4 | $211K | Hold |
4,045
| – | – | 0.03% | 305 |
|
|
2016
Q3 | $211K | Sell |
4,045
-2,204
| -35% | -$121K | 0.03% | 302 |
|
|
2016
Q2 | $338K | Sell |
6,249
-953
| -13% | -$50.2K | 0.05% | 235 |
|
|
2016
Q1 | $372K | Sell |
7,202
-1,821
| -20% | -$90.7K | 0.04% | 238 |
|
|
2015
Q4 | $454K | Buy |
9,023
+1,299
| +17% | +$66.2K | 0.08% | 182 |
|
|
2015
Q3 | $371K | Sell |
7,724
-195
| -2% | -$10.2K | 0.06% | 211 |
|
|
2015
Q2 | $412K | Buy |
7,919
+611
| +8% | +$34.4K | 0.06% | 216 |
|
|
2015
Q1 | $426K | Buy |
7,308
+605
| +9% | +$34.7K | 0.06% | 225 |
|
|
2014
Q4 | $357K | Sell |
6,703
-16,842
| -72% | -$942K | 0.05% | 239 |
|
|
2014
Q3 | $1.35M | Sell |
23,545
-5,510
| -19% | -$338K | 0.21% | 125 |
|
|
2014
Q2 | $1.82M | Buy |
29,055
+2,633
| +10% | +$178K | 0.26% | 110 |
|
|
2014
Q1 | $1.76M | Buy |
26,422
+1,460
| +6% | +$98.7K | 0.25% | 102 |
|
|
2013
Q4 | $1.63M | Buy |
24,962
+2,628
| +12% | +$170K | 0.24% | 98 |
|
|
2013
Q3 | $1.4M | Buy |
22,334
+11,868
| +113% | +$764K | 0.23% | 107 |
|
|
2013
Q2 | $654K | Buy |
+10,466
| New | +$664K | 0.33% | 31 |
|
Other funds holding GSK
JEST
First Horizon Advisors's GSK Position: Q2 2025 in Review
First Horizon Advisors increased its GSK (GSK) stake by 209% in Q2 2025, buying an estimated $81.5K and bringing the position to 3,155 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #662.
First Horizon Advisors first reported a position in GSK in Q2 2013 and has held it in 49 quarters since. The position peaked at $1.82M in Q2 2014. 891 funds tracked by Wall St. Rank hold GSK as of Q2 2025.
- First Horizon Advisors held 3,155 shares of GSK worth $121K as of Q2 2025.
- First Horizon Advisors bought 2,134 GSK shares in Q2 2025, an estimated $81.5K.
- GSK made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #662 holding.
- First Horizon Advisors first reported a position in GSK in Q2 2013 and has held it in 49 quarters since.
- First Horizon Advisors's GSK position peaked at $1.82M in Q2 2014.
- 891 funds tracked by Wall St. Rank held GSK as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.